Showing results (1701-1710 of 4,515) with videos related to

Sort By:
Pageof 452
Advances in Therapy|November 14, 2015
Characteristics Relating to Adherence and Persistence to Basal Insulin Regimens Among Elderly Insulin-Naïve Patients with Type 2 Diabetes: Pre-Filled Pens versus Vials/SyringesS Lane Slabaugh, Jonathan R Bouchard, Yong Li, et al.
Advances in Therapy|December 10, 2015
Cost Analyses in the US and Japan: A Cross-Country Comparative Analysis Applied to the PRONOUNCE Trial in Non-Squamous Non-Small Cell Lung CancerLisa M Hess, Narayan Rajan, Katherine Winfree, et al.
Advances in Therapy|November 17, 2017
Systematic Literature Review of the Impact of Endocrine Monotherapy and in Combination with Targeted Therapy on Quality of Life of Postmenopausal Women with HR+/HER2- Advanced Breast CancerZhou Zhou, Derek H Tang, Jipan Xie, et al.
Advances in Therapy|October 28, 2017
Clinical and Economic Outcomes in Elderly Advanced Renal Cell Carcinoma Patients Starting Pazopanib or Sunitinib Treatment: A Retrospective Medicare Claims AnalysisNicholas J Vogelzang, Sumanta K Pal, Sameer R Ghate, et al.
Advances in Therapy|November 23, 2017
Dispensing Patterns of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration: A Retrospective Cohort Study in AustraliaAdrian Skelly, Hans-Joachim Carius, Vladimir Bezlyak, et al.
Advances in Therapy|July 8, 2016
Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need?Janet B McGill, David Ahn, Steven V Edelman, et al.
Advances in Therapy|July 15, 2017
Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart FailureElizabeth Ofili, Inder Anand, Richard Allen Williams, et al.
Advances in Therapy|August 19, 2017
Efficacy and Safety of Linagliptin in 2681 Asian Patients Stratified by Age, Obesity, and Renal Function: A Pooled Analysis of Randomized Clinical TrialsGuang Ning, Tushar Bandgar, Uwe Hehnke, et al.
Advances in Therapy|July 5, 2016
Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with MethotrexateAlberto Batticciotto, Roberto Ravasio, Marta Riva, et al.
Advances in Therapy|February 17, 2018
Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United StatesAhmed M Soliman, Eric Surrey, Machaon Bonafede, et al.
Pageof 452